This webinar will give you a “sneak peek” into the findings that will be presented at the 12th Global Cardio Vascular Clinical Trialists Forum, December 3-5 at the French Embassy, Washington D.C.

You’ll hear from scheduled speakers who will share abridged versions of the talks to be presented at the Forum. And, you will be able to ask questions of these international experts.

Speakers

For Speaker Bios, Click Here

Jeffrey S. Borer, M.D.
Prof. of Medicine, Cell Biology, Radiology, & Surgery
Director, The Howard Gilman Institute for Heart Valve Diseases and The Schiavone Cardiovascular Translational Institute

Carolyn Lam Su Ping
MBBS, MRCP, MS, FACC, FESC
Senior Consultant of the National Heart Centre, Singapore
Associate Professor of Duke-NUS Cardiovascular Academic Clinical Program
Chairperson of the Asia Pacific Association of Women’s Cardiovascular Disease

Bertram Pitt (Ann Arbor, USA)
Professor of Medicine emeritus
University of Michigan School of Medicine

Faiez Zannad (Nancy, FRA)
Professor of Therapeutics and Cardiology,
Université de Lorraine, France &
Director of the Clinical Investigation Center,
InsermCHU of Nancy.

At the CVCT Forum, presenters will provide a deep dive into this year’s results, share the stories behind the studies and be available to network with world leaders in cardiovascular trials. The DVDT Forum provides, by far, the best annual update and in-depth understanding of the trials shaping the evidence base of modern cardiology.

At CVCT Forum, practitioners and young investigators learn the science of clinical trials from trial protocol design to trial result interpretation. In addition, they identify emerging important issues in CV medicine and opportunities for new trials. Further, participants explore the evidence from clinical trials and how results may be incorporated into treatment guidelines.

Preliminary program:
http://www.globalcvctforum.com/program/program-2015

Join us for the whole picture on trials in the following fields:
•         Atherosclerosis
•         Biomarkers and personalized medicine
•         Cardiorenal
•         Devices and telemonitoring
•         Diabetes and weight loss
•         Heart failure
•         Interventional cardiology
•         Thrombosis

Testimonial

“I have never interacted with a greater concentration of key opinion leaders in the same small space and time.
The meeting has already led to new potential collaborations and opportunities for funding.”
Lars Lund, Cardiologist and Heart Failure Specialist,
Director of the Mechanical Circulatory Support Program, &
Associate Professor, Karolinska University Hospital, Sweden

“It was a pleasure to attend this year's CVCT meeting. As a first-time attendee,
I was extremely impressed with the scope and quality of the session.”
Susan Czajkowski, Program Director, NHLBI, USA​